These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4069883)

  • 1. [Changes in the diabetogenic factor activity in the blood plasma of children with diabetes mellitus resulting from systematic heparin administration].
    Kudriashov BA; Zhukovskiĭ MA; Shcherbacheva LN; Ul'ianov AM; Bazaz'ian GG
    Pediatriia; 1985 Aug; (8):46-7. PubMed ID: 4069883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recovery of the anticoagulation system function in patients with insulin-dependent diabetes by neutralization of the activity of diabetogenic factor].
    Kudriashov BA; Balabolkin MI; Ul'ianov AM; Liapina LA; Levitskaia ZI
    Vopr Med Khim; 1990; 36(3):79-81. PubMed ID: 2382439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [C-peptide, diabetogenic factor and the blood anticoagulating system in patients with the insulin-dependent type of diabetes mellitus before and after heparin therapy].
    Balabolkin MI; Kudriashov BA; Levitskaia ZI; Liapina LA; Ul'ianov AM
    Probl Endokrinol (Mosk); 1990; 36(1):25-8. PubMed ID: 2330356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation and various physico-chemical properties of diabetogenic factor from the blood of patients with diabetes].
    Kudriashov BA; Liapina LA; Azieva LD
    Vopr Med Khim; 1989; 35(6):63-6. PubMed ID: 2629241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural diabetogenic factor].
    Kudriashov BA
    Sov Med; 1989; (7):51-4. PubMed ID: 2678523
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complex-formation of heparin with the plasma diabetogenic factor].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1986; 32(2):64-5. PubMed ID: 3705518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dependence of the blood plasma activity of the diabetogenic factor in animals on the functional depression of the anticoagulating system induced by an atherogenic diet].
    Kudriashov BA; Ul'ianov AM; Bazaz'ian GG
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1986; (2):50-3. PubMed ID: 3697425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetogenic factor in the blood plasma in diabetes mellitus].
    Kudriashov BA; Ponasenkova GV; Pytel' IuA
    Probl Endokrinol (Mosk); 1982; 28(5):61-4. PubMed ID: 7145885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-dependent diabetogenic factor in the plasma of children with diabetes mellitus].
    Zhukovskii MA; Kudriashov BA; Ul'ianov AM; Shcherbacheva LN; Tarasov IuA
    Pediatriia; 1985 Feb; (2):7-9. PubMed ID: 3991307
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of endogenous heparin in the protection against risk factors causing experimental diabetes].
    Kudriashov BA; Ul'ianov AM; Tarasov IuA
    Vopr Med Khim; 1989; 35(6):80-2. PubMed ID: 2629244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of the diabetogenic factor in hypercoagulation of the blood].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Fiziol Zh SSSR Im I M Sechenova; 1986 Mar; 72(3):373-6. PubMed ID: 3709867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The toxic action of the "diabetogenic factor" metabolite in the body during the development of insulin-dependent diabetes].
    Kudriashov BA
    Izv Akad Nauk Ser Biol; 1993; (5):694-702. PubMed ID: 8220079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional changes in the state of the insular system of animals after intravenous administration of diabetogenic factor].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Vopr Med Khim; 1986; 32(5):57-9. PubMed ID: 3535246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidiabetic properties of high molecular weight heparin-adenosine triphosphate complex].
    Ul'ianov AM; Liapin LA; Pastorova VE
    Izv Akad Nauk Ser Biol; 2006; (1):77-80. PubMed ID: 16521542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stable reduction of endogenous insulin production in the body in experimental insulin-dependent diabetes].
    Kudriashov BA; Ul'ianov AM
    Vopr Med Khim; 1991; 37(4):40-3. PubMed ID: 1750208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the pancreas in the appearance of the diabetogenic factor during the development of alloxan diabetes].
    Kudriashov BA; Tarasov IuA; Ul'ianov AM
    Patol Fiziol Eksp Ter; 1989; (3):75-9. PubMed ID: 2797907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the diabetogenic factor in the activation of the blood coagulation system in experimental alloxan diabetes].
    Kudriashov BA; Ul'ianov AM; Liapina LA
    Patol Fiziol Eksp Ter; 1986; (4):44-7. PubMed ID: 3797076
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physicochemical properties of the diabetogenic factor and its complex with heparin].
    Kudriashov BA; Ammosova IaM; Liapina LA; Ul'ianov AM
    Farmakol Toksikol; 1987; 50(3):49-52. PubMed ID: 3609278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period).
    Koert M; Nowak-Göttl U; Kreuz W; Grüttner HP; Kornhuber B; Breddin HK
    Klin Padiatr; 1991; 203(6):429-32. PubMed ID: 1721940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The blood anticoagulant system in rats perorally administered a heparin-acetylsalicylic acid complex].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1991; (4):625-30. PubMed ID: 1787232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.